Treatment Approach for Secondary Hypertension
The treatment of secondary hypertension must focus on identifying and addressing the underlying cause while maintaining blood pressure control to reduce morbidity and mortality. 1
Identification of Secondary Hypertension
Secondary hypertension accounts for 5-10% of all hypertension cases and requires specific clinical clues for detection:
Clinical Red Flags
- Abrupt onset of hypertension
- Hypertension onset before age 30
- Accelerated/malignant hypertension
- Sudden loss of BP control in previously controlled patients
- Use of BP-raising substances (NSAIDs, amphetamines, immunosuppressants)
- Resistant or refractory hypertension
- Unprovoked/excessive hypokalemia
- Onset of diastolic hypertension in older patients (≥65 years) 2
Diagnostic Workup
For suspected secondary hypertension, the following tests are recommended:
| Suspected Cause | Recommended Screening Test |
|---|---|
| Primary aldosteronism | Aldosterone-to-renin ratio |
| Renovascular hypertension | Renal Doppler ultrasound, CT/MR angiography |
| Pheochromocytoma | 24h urinary/plasma metanephrines and normetanephrines |
| Obstructive sleep apnea | Overnight polysomnography |
| Renal parenchymal disease | Renal ultrasound, urinalysis, eGFR |
| Cushing's syndrome | 24h urinary free cortisol, dexamethasone suppression |
| Thyroid disease | TSH |
| Hyperparathyroidism | PTH, calcium, phosphate |
| Coarctation of aorta | Echocardiogram, CT angiogram |
Treatment Strategies
1. Obstructive Sleep Apnea
- CPAP therapy for moderate to severe cases
- Weight loss program
- Continue antihypertensive medications as needed 1
- Sleep apnea is commonly encountered in resistant and refractory hypertension 2
2. Primary Aldosteronism
- Unilateral disease: Adrenalectomy is treatment of choice
- Bilateral disease (~60% of cases): Mineralocorticoid receptor antagonists (spironolactone, eplerenone) 2, 1
- Primary aldosteronism prevalence is approximately 20% in patients with resistant hypertension 2
3. Renovascular Hypertension
- Medical therapy is recommended for most patients with atherosclerotic renal artery stenosis
- Consider revascularization only in select cases with critical stenosis and specific clinical presentations 2, 1
- Medication regimen should include RAS blockers (ACE inhibitors or ARBs) unless contraindicated 1
4. Pheochromocytoma
- Surgical removal after adequate alpha-blockade
- Critical: Alpha-blockers must be initiated before beta-blockers to prevent hypertensive crisis 1
5. Medication-Induced Hypertension
- Discontinue or modify offending medications when possible
- Common culprits: NSAIDs, oral contraceptives, steroids, immunosuppressants 2, 1
Pharmacological Management During Workup
While investigating the underlying cause, blood pressure control remains essential:
First-line agents include:
For resistant hypertension:
- Add low-dose spironolactone (25 mg daily)
- If intolerant to spironolactone, consider eplerenone, amiloride, higher dose diuretics, or addition of bisoprolol/doxazosin 1
Important Considerations
- Medication adherence should always be assessed before extensive workup for secondary causes 1
- Continue antihypertensive therapy during the diagnostic workup 1
- Regular BP monitoring (both home and office) is essential for management 1
- Even after treating the underlying cause, residual hypertension often persists due to vascular remodeling or concomitant essential hypertension 4
- For truly resistant cases, referral to specialized hypertension centers should be considered 1
Pitfalls to Avoid
- Delayed diagnosis: Secondary hypertension is often underrecognized, leading to preventable target organ damage 5
- Premature beta-blockade in suspected pheochromocytoma can precipitate hypertensive crisis 1
- Overlooking medication-induced causes: Always review all medications, including over-the-counter drugs 2
- Assuming complete cure: Despite treating the underlying cause, many patients will still require antihypertensive medications long-term 4
Remember that early detection and treatment of secondary hypertension are crucial to minimize irreversible vascular changes and reduce morbidity and mortality from hypertension-related complications.